Post-effective amendment to a registration statement that is not immediately effective upon filing

SUBSEQUENT EVENT (Details) - Schedule of Proforma Consolidated Balance Sheets

SUBSEQUENT EVENT (Details) - Schedule of Proforma Consolidated Balance Sheets (USD $)	Jan. 31, 2015	Oct. 31, 2014	Jan. 31, 2014	Oct. 31, 2013	Oct. 31, 2012
Current assets:
Cash and cash equivalents	$ 7,809,564	$ 3,361,246	$ 776,141	$ 898,172	$ 339,693
Short-term investments in certificates of deposit	2,650,000us-gaap_ShortTermInvestments	2,500,000us-gaap_ShortTermInvestments
Accounts receivable	45,000us-gaap_AccountsReceivableNetCurrent	400,000us-gaap_AccountsReceivableNetCurrent		175,000us-gaap_AccountsReceivableNetCurrent
Prepaid expense and other current assets	66,499	60,577		160,646
Total current assets	10,571,063us-gaap_AssetsCurrent	6,321,823us-gaap_AssetsCurrent		1,233,818us-gaap_AssetsCurrent
Patent, net of accumulated depreciation of $314,453	2,640,334itus_FiniteLivedPatentsNet	2,721,658itus_FiniteLivedPatentsNet
Property and equipment, net	58,995us-gaap_PropertyPlantAndEquipmentNet	11,875us-gaap_PropertyPlantAndEquipmentNet		8,379us-gaap_PropertyPlantAndEquipmentNet
Total assets	13,270,392us-gaap_Assets	9,055,356us-gaap_Assets		5,439,538us-gaap_Assets
Current liabilities:
Accounts payable and accrued expenses	1,401,645	1,249,426		1,276,470
Royalties and contingent legal fees	265,708	560,076		207,743
Total current liabilities	1,667,353us-gaap_LiabilitiesCurrent	1,809,502us-gaap_LiabilitiesCurrent		3,211,533us-gaap_LiabilitiesCurrent
Patent acquisition obligation	3,345,467itus_PatentAcquisitionObligation	3,236,281itus_PatentAcquisitionObligation
Total liabilities	5,012,820us-gaap_Liabilities	5,045,783us-gaap_Liabilities		8,760,131us-gaap_Liabilities
Preferred stock	350,000us-gaap_PreferredStockValue	350,000us-gaap_PreferredStockValue
Common stock, par value $.01 per share	2,197,122us-gaap_CommonStockValue	2,196,922us-gaap_CommonStockValue		2,092,767us-gaap_CommonStockValue
Additional paid-in capital	146,727,952us-gaap_AdditionalPaidInCapital	146,232,373us-gaap_AdditionalPaidInCapital		134,750,048us-gaap_AdditionalPaidInCapital
Accumulated deficit	(141,017,502)	(144,769,722)		(135,163,408)
Total shareholder’s equity	8,257,572us-gaap_StockholdersEquity	4,009,573us-gaap_StockholdersEquity		(3,320,593)us-gaap_StockholdersEquity	(1,194,056)us-gaap_StockholdersEquity
Total liabilities and shareholders’ equity	13,270,392	9,055,356		5,439,538
Series A Preferred Stock [Member]
Current liabilities:
Preferred stock	350,000	350,000
Preferred Stock [Member]
Current liabilities:
Preferred stock
Total shareholder’s equity	350,000	350,000
Pro Forma [Member]
Current assets:
Cash and cash equivalents		8,861,246
Short-term investments in certificates of deposit		2,500,000
Accounts receivable		400,000
Prepaid expense and other current assets		60,577
Total current assets		11,821,823
Patent, net of accumulated depreciation of $314,453		2,721,658
Property and equipment, net		11,875
Total assets		14,555,356
Current liabilities:
Accounts payable and accrued expenses		1,047,466
Royalties and contingent legal fees		560,076
Total current liabilities		1,607,542
Patent acquisition obligation		3,236,281
Total liabilities		4,843,823
Preferred stock		350,000
Common stock, par value $.01 per share		2,196,922
Additional paid-in capital		146,232,373
Accumulated deficit		(139,067,762)
Total shareholder’s equity		9,711,533
Total liabilities and shareholders’ equity		$ 14,555,356